Lyophilized peptide storage and shipping: what the evidence must show
Freeze-drying does not establish a universal shelf life or temperature tolerance. Stability needs evidence for the specific material, formulation, packaging, conditions and time. FSD maintains products at 2°C before dispatch, but its heat-resistant packaging is not a guarantee of refrigerated or temperature-controlled transport.
What lyophilization changes
Lyophilization removes water through a controlled freeze-drying process. Residual moisture can still matter, and the finished material needs its own stability assessment. A dry-looking cake does not verify chemical integrity or quantify remaining water.
FDA's technical discussion of lyophilized products treats moisture, stability and appearance as separate considerations. It is background on the process, not evidence that an FSD vial has a particular shelf life or is suitable for administration.
Match a stability claim to the material
Look for stability data identifying the material, formulation, packaging, conditions, duration and attributes tested. Evidence for one configuration does not automatically apply to another.
A single COA reports tests at one point. It does not establish shelf life or demonstrate how the material changes throughout storage.
Read FSD's storage and transport statement precisely
Products are maintained at 2°C in cold storage before dispatch and sent in heat-resistant protective packaging. FSD does not guarantee refrigerated or temperature-controlled transport, and does not make a blanket room-temperature stability or shelf-life guarantee.
This distinction matters when designing receipt criteria for laboratory work. Pre-dispatch storage information does not document the parcel's temperature throughout transit.
Keep a useful receipt record
Follow the product-specific information supplied. If it is missing, or if a shipment raises concerns, ask support for available storage and batch records. A visibly intact parcel does not verify its temperature history. Handle any unresolved question through your laboratory's established material-assessment process.
| Record | Why it helps |
|---|---|
| Order, product, strength and visible identifiers | Connects your concern to the supplied material. |
| Delivery time and packaging photographs | Preserves what could be observed on receipt. |
| Any available temperature record | Provides evidence beyond packaging appearance. |
| Supplied storage instructions and support response | Keeps the basis for your laboratory's decision together. |
Avoid a pass/fail judgment from temperature alone
Without the exposure history and applicable stability evidence, parcel temperature cannot quantify degradation. Record what is known and missing. Do not invent an expiry date from the COA's age.
Common questions
Can I assume all lyophilized peptides tolerate room-temperature shipping?
No universal assurance follows from freeze-drying. Any tolerance claim needs evidence relevant to the particular material, packaging, temperature and exposure time.
Does heat-resistant packaging prove the parcel stayed at 2°C?
No. FSD's 2°C statement concerns storage before dispatch. Protective packaging is not a verified record of refrigerated or temperature-controlled transit.
Sources & scope
These references explain analytical and research principles. They do not certify FSD BIO LABS or provide evidence about a particular FSD batch.
- ICH Q1A(R2): Stability Testing of New Drug Substances and Products — EMA / ICH
Stability evidence is tied to material, formulation, container, conditions and time; storage statements and shelf life need supporting data. The EMA landing page lists this as the effective version. - Lyophilization of Parenteral (7/93) — FDA
Historical technical background on freeze-drying, residual moisture, cake appearance and the need for stability testing. No parenteral suitability is inferred for FSD products.